Dendris Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Dendris General Information


Developer of a biotechnological chip designed to perform syndromic diagnosis of infectious bacteria in four hours. The company's chip performs a syndromic test allowing to analyze 11 bacteria simultaneously based on the functionalization of the support by phosphorus dendrimers, enabling clinicians to diagnose causes of illness in a reliable and cost-effectives manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 335 rue du chene vert
  • 31670 Labège
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dendris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 07-Mar-2008 Completed Startup
To view Dendris’s complete valuation and funding history, request access »

Dendris Patents

Dendris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2995614-B1 Biopuce for the detection and / or identification of bacteria of the genus legionella, kit and method of use Active 19-Sep-2012 000000000
FR-2995614-A1 Biochip used to detect legionella bacteria in e.g. water sample, includes specific rna polymerase beta subunit nucleic acid molecule that hybridizes with portion of sequence of subunit gene of bacteria and is immobilized on support Granted 19-Sep-2012 000000000

Dendris Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nubbo Accelerator/Incubator 000 0000 000000 0
To view Dendris’s complete investors history, request access »